Brochure | July 3, 2020

Kindeva Hollow Microstructured Transdermal System

Powerful cancer vaccines are one part of the cancer treatment puzzle. Kindeva Hollow Microstructured Transdermal System (hMTS) is designed to help your vaccine reach its treatment potential through intradermal delivery. It’s time to approach clinical trials with confidence.

Why intradermal delivery?

  • Potential for enhanced immune response

Why Kindeva hMTS?

  • Easy, consistent, reproducible intradermal delivery
  • Higher volumes vs. other intradermal delivery devices
VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: